Article
Frequent loss-of-heterozygosity in CRISPR-Cas9-edited early human embryos
2020-06-05
Abstract excerpt
CRISPR-Cas9 genome editing is a promising technique for clinical applications, such as the correction of disease-associated alleles in somatic cells. The use of this approach has also been discussed in the context of heritable editing of the human germline. However, studies assessing gene correction in early human embryos report low efficiency of mutation repair, high rates of mosaicism and the possibility of unin...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- e6df0390-53ef-5996-bb2f-889d029a6915
- DOI
- 10.1101/2020.06.05.135913
